LIEBMAN SEYMOUR 4
4 · T2 Biosystems, Inc. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
LIEBMAN SEYMOUR
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-01-01+34,188→ 34,188 total→ Common Stock (34,188 underlying) - Award
Restricted Stock Units
2021-01-01+32,258→ 32,258 total→ Common Stock (32,258 underlying) - Exercise/Conversion
Common Stock
2021-01-01+34,188→ 84,185 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2022.
- [F3]On January 1, 2020 the reporting person was granted 34,188 restricted stock units that vested on January 1, 2021.